Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis

Liver International

Volumn 30, Issue 5, 2010, Pages 733-740

  Berry, P A ^a   Antoniades, C G ^a   Hussain, M J ^a   McPhail, M J W ^a   Bernal, W ^a   Vergani, D ^a   Wendon, J A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Anti inflammatory response; Cytokine; Immunoparesis; Multiple organ failure; Systemic inflammatory response

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; PARACETAMOL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DECOMPENSATED LIVER CIRRHOSIS; FOLLOW UP; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PREDICTOR VARIABLE; PROGNOSIS;

COHORT STUDIES; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; PATIENT ADMISSION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954378413     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2010.02219.x     Document Type: Article

References (35)

1. Rolando N, Wade J, Davalos M. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32((Part 1)):734-9.
2. Wasmuth HE, Kunz D, Yagmur E. Patients with acute on chronic liver failure display " sepsis-like" immune paralysis. J Hepatol 2005, 42:195-201.
3. dos Santos DC, da Silva Gomes Martinho JM, Pacheco-Moreira LF. Eosinophils involved in fulminant hepatic failure are associated with high interleukin-6 expression and absence of interleukin-5 in liver and peripheral blood. Liver Int 2009, 29:544-51.
4. Ruiz-del-Arbol L, Urman J, Fernandez J. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003, 38:1210-8.
5. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-8.
6. Pinsky MR, Vincent JL, Deviere J. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993, 103:565-75.
7. Oberholzer A, Souza SM, Tschoeke SK. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 2005, 23:488-93.
8. Heper Y, Akalin EH, Mistik R. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006, 25:481-91.
9. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997, 112:235-43.
10. Herrero C, Hu X, Li WP. Reprogramming of IL-10 activity and signaling by IFN-gamma. J Immunol 2003, 171:5034-41.
11. Yumoto E, Higashi T, Nouso K. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002, 17:285-94.
12. Karp CL, Wysocka M, Ma X. Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 1998, 28:3128-36.
13. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-20.
14. Osuchowski MF, Welch K, Siddiqui J, Remick DG. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 2006, 177:1967-74.
15. Antoniades CG, Berry PA, Davies ET. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006, 44:34-43.
16. Berres ML, Schnyder B, Yagmur E. Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis. Liver Int 2009, 29:536-43.
17. Monneret G, Finck ME, Venet F. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 2004, 95:193-8.
18. Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos CA. Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections. Clin Diagn Lab Immunol 2004, 11:161-7.
19. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439-45.
20. Bernuau J, Goudeau A, Poynard T. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986, 6:648-51.
21. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359:558-63.
22. Antoniades CG, Berry PA, Bruce M. Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis. Liver Transpl 2007, 13:1254-61.
23. Schiodt FV, Ostapowicz G, Murray N. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl 2006, 12:1776-81.
24. Cholongitas E, Senzolo M, Patch D. Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics. Aliment Pharmacol Ther 2006, 24:453-64.
25. Cholongitas E, Betrosian A, Senzolo M. Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission. J Gastroenterol Hepatol 2008, 23:1233-7.
26. Ho YP, Sheen IS, Chiu CT, Wu CS, Lin CY. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 2006, 101:1117-24.
27. Satoh A, Miura T, Satoh K. Human leukocyte antigen-DR expression on peripheral monocytes as a predictive marker of sepsis during acute pancreatitis. Pancreas 2002, 25:245-50.
28. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990, 77:204-7.
29. Giannoudis PV, Smith RM, Perry SL. Immediate IL-10 expression following major orthopaedic trauma: relationship to anti-inflammatory response and subsequent development of sepsis. Intensive Care Med 2000, 26:1076-81.
30. Ozbalkan Z, Aslar AK, Yildiz Y, Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract 2004, 58:125-9.
31. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 1995, 75:724-33.
32. Kuhns DB, Alvord WG, Gallin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995, 171:145-52.
33. Marchant A, Deviere J, Byl B. Interleukin-10 production during septicaemia. Lancet 1994, 343:707-8.
34. Yeh FL, Lin WL, Shen HD. Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients. Burns 2000, 26:454-9.
35. Stadlbauer V, Krisper P, Aigner R. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 2006, 10:R169.